Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Total Liabilities

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) currently reports a total liabilities of $16M as of June 2026. That compares with $20M in the prior-year period — down 20.5% year over year. Use the charts on this page to explore Deep Medicine Acquisition - Tradeable Rights - Oct 2026's total liabilities history and peer comparisons.

Deep Medicine Acquisition - Tradeable Rights - Oct 2026's total liabilities decreased from $20M to $16M — a 20.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 reported $16M in total liabilities as of June 2026. That compares with $20M in the prior-year period — down 20.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Deep Medicine Acquisition - Tradeable Rights - Oct 2026, and consider following DMAQR for alerts when major investors trade the stock.